Structures by: Anzini M.
Total: 7
N-((1-butylpiperidin-4-yl)methyl)-8-hydroxyquinoline-2-carboxamide hydrate
C20H27N3O2,H2O
MedChemComm (2018) 9, 9 1466-1471
a=11.3833(6)Å b=11.7128(6)Å c=15.0977(8)Å
α=90° β=103.830(6)° γ=90°
4-chloro-N-(3-(piperidin-1-yl)propyl)quinoline-2-carboxamide
C18H22ClN3O
MedChemComm (2018) 9, 9 1466-1471
a=37.512(5)Å b=7.280(5)Å c=12.978(5)Å
α=90° β=90° γ=90°
6,7-dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline
C22H23N3O,0.13H2O
Acta Crystallographica Section C (1997) 53, 7 987-990
a=15.0089(14)Å b=16.952(2)Å c=22.124(2)Å
α=90° β=96.172(6)° γ=90°
7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline
C21H21N3O1
Acta Crystallographica Section C (1998) 54, 8 1127-1130
a=12.415(2)Å b=10.806(2)Å c=13.253(3)Å
α=90° β=102.83(3)° γ=90°
2-Ethoxycarbonyl-3-(4-methylphenyl)-1H-indene-1-spirocyclopropane
C21H20O2
Journal of Organic Chemistry (2003) 68, 9473-9476
a=35.395(4)Å b=5.9840(10)Å c=16.147(2)Å
α=90° β=90° γ=90°
Ethyl 3-(4-methylphenyl)-1-oxo-1H-indene-2-carboxylate
C19H16O3
Journal of Organic Chemistry (2003) 68, 9473-9476
a=8.9030(10)Å b=8.9930(10)Å c=10.9270(10)Å
α=110.050(10)° β=95.090(10)° γ=109.17°
Ethyl 1-hydroxy-1-methyl-3-(4-methylphenyl)-1H-indene-2-carboxylate
C20H20O3
Journal of Organic Chemistry (2003) 68, 9473-9476
a=5.8050(10)Å b=10.2310(10)Å c=15.0150(10)Å
α=76.63° β=84.390(10)° γ=77.470(10)°